The global animal model market, valued at USD 2.41 billion in 2023, is anticipated to witness robust growth, reaching USD 4.20 billion by 2031, with a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2024 to 2031. This expansion is primarily driven by increasing research activities in pharmaceutical and biotechnology sectors, where animal models serve as essential tools for studying diseases, developing new drugs, and ensuring their safety.
Moreover, the demand for personalized medicine and targeted therapies is accelerating the market's growth trajectory. Animal models play a crucial role in preclinical research, offering insights into disease mechanisms and enabling the testing of novel therapeutic approaches. As technological advancements enhance the precision and applicability of these models, their adoption is expected to grow further, fostering innovation in biomedical research and improving healthcare outcomes globally.
Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3789
Key Players
Major companies in the animal model market include:
- Charles River Laboratories International, Inc.
- Envigo Corporation (Now part of Labcorp)
- Taconic Biosciences, Inc.
- JANVIER LABS
- genOway S.A.
- Horizon Discovery Group plc
- Trans Genic Inc.
- Ingenious Targeting Laboratory, Inc.
- Harbour BioMed (formerly Harbour Antibodies BV)
- Crown Bioscience Inc.
- Other players
Market Analysis
The growth of the animal model market is driven by:
- Increasing Research in Biomedical and Pharmaceutical Fields: Demand for animal models in drug discovery and development.
- Technological Advancements: Development of genetically engineered animal models.
- Rising Prevalence of Chronic Diseases: Need for better understanding and treatment options.
Key Segments
By Type:
- Transgenic Models
- Knockout Models
- Hybrid/Congenic Models
- Inbred Models
- Outbred Models
- Others
By Application:
- Basic Research
- Drug Discovery and Development
- Toxicology
- Cancer Research
- Other Applications
By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutions
- Other End Users
Regional Analysis
North America and Europe are anticipated to dominate the animal model market due to extensive research activities and well-established pharmaceutical industries. Asia Pacific is expected to witness significant growth, driven by increasing investments in biomedical research and development.
Key Takeaways
- The animal model market is experiencing steady growth, supported by advancements in genetic engineering and increasing demand for personalized medicine.
- Transgenic and knockout models are expected to remain prominent due to their utility in studying genetic mechanisms and disease pathways.
- Collaborations between pharmaceutical companies and research institutions are likely to drive innovation and market expansion.
About Us
SNS Insider is a leading market research and consulting agency providing comprehensive insights into global markets. We specialize in delivering accurate market data and strategic recommendations to our clients worldwide.
Other Related Reports
Cosmetic Dentistry Market Technology
Degenerative Disc Disease Treatment Market Technology
Dental Biomaterials Market Technology
Dental Bone Graft And Substitutes Market Technology
Contact Us
Akash Anand – Head of Business Development & Strategy
Email: info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: SNS Insider
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian